Severe hypertriglyceridaemia associated with human immunodeficiency virus and highly active antiretroviral therapy

Annals of Clinical Biochemistry

Volumn 39, Issue 4, 2002, Pages 409-413

  Carling, R S ^a   Hextall, R ^a   DeSilva, P A ^b   Barth, J H ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b District Hospital NHS Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BEZAFIBRATE; CHOLESTEROL; DIDANOSINE; EFAVIRENZ; FIBRIC ACID DERIVATIVE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; TRIACYLGLYCEROL; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LACTIC ACIDEMIA; LIPODYSTROPHY; MALE; MYOPATHY; PANCREATITIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RISK ASSESSMENT; SYMPTOM; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLOOD GLUCOSE; CHOLESTEROL; HIV; HIV INFECTIONS; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; TRIGLYCERIDES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036306683     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/000456302760042191     Document Type: Article

References (25)

1. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
2. The hypertriglyceridaemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B
3. Influence of protease inhibitor therapy on lipoprotein metabolism
4. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance due to HIV-1 protease inhibitor
5. Marked hypertriglyceridemia associated with ritonavir therapy
6. Ritonavir, triglycerides and pancreatitis
7. Use of fenofibrate in the management of protease inhibitor-associated lipid abnormalities
8. Lipemia retinalis in acquired immunodeficiency syndrome treated with protease inhibitors
9. Acute pancreatitis as a complication of ritonavir therapy in a patient with AIDS
10. Intervention for hyperlipidaemia associated with protease inhibitors
11. Severe premature coronary artery disease with protease inhibitors
12. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
13. Circulating interferon alpha levels and hypertriglyceridaemia in the acquired immune deficiency syndrome
14. Lipids, lipoproteins, triglyceride clearance and cytokines in human immunodeficiency virus infection and the acquired immune deficiency syndrome
15. Lipodystrophy in HIV positive patients treated with protease inhibitors. Current problems in pharmacovigilance
16. Metabolic abnormalities and use of HIV-1 protease inhibitors
17. Diagnosis, prediction and natural course of HIV-1 protease inhibitor-associated lipodystrophy, hyperlipidaemia and diabetes mellitus: A cohort study
18. Redistribution of body fat in HIV infected women undergoing combined antiretroviral therapy
19. Pathogenesis of HIV-1 protease inhibitor associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
20. Serum triglycerides, HIV infection and highly active antiretroviral therapy, Aquitaine Cohort, France 1996 to 1998
21. Effects of protease inhibitors on hyperglycaemia, hyperlipidaemia and lipodystrophy. A 5 year cohort study
22. Hyperlipidaemia and insulin resistance are induced by protease inhibitors independent if changes in body fat composition
23. Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects
24. Hyperlipidaemia associated with protease inhibitor therapy
25. Myocardial infarction in HIV-infected men receiving protease inhibitors